FDA Efforts in Patient Engagement
Summary
In recent years, stakeholders have increasingly become aware of the potential opportunities surrounding incorporation of the patient perspective into early stages of drug development. Listen to Debleena Sengupta discuss how patient input is evaluated and incorporated into the FDA's decision-making process.Recent Podcasts
Related Content


What the Rollover from Drugs to Biologics Means
On Monday, March 23, over 90 products that had historically been regulated as drugs were deemed to b...

FDA’s Priorities and Approach for Homeopathic Drug Products
On October 24, the FDA released a draft guidance describing the intended risk-based approach for reg...
Services
From beginning to end, our team synergy
produces measurable results. Let's work together.
produces measurable results. Let's work together.

Patient Engagement
Connect Decision Makers

Value-Based Care Solutions
Demonstrate Evidence-Based Results

Healthcare Transformation
Improve Healthcare